| Financial Year |
March 31 2023 |
| Monetary Funds |
100,301,263.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,294,604.77 |
| Accounts Receivable |
238,014,282.72 |
| Advances to Suppliers |
9,598,127.08 |
| Other Receivables |
1,760,698.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
170,782,853.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,036,625.92 |
| Total Current Assets |
565,983,994.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
158,485,090.68 |
| Under-construction Projects |
3,709,734.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,973,779.22 |
| R&D expenses |
-- |
| Goodwill |
56,021,962.54 |
| Long-Term Deferred and Prepaid Expenses |
9,226,535.87 |
| Deferred Income Tax Assets |
10,343,024.73 |
| Other Non-Current Assets |
3,440,184.35 |
| Sub-Total of Non-Current Assets |
280,976,175.42 |
| Total Assets |
846,960,170.02 |
| Short-Term Loans |
92,504,935.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
59,535,528.54 |
| Accounts Payable |
100,638,391.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,924,329.55 |
| Taxes Payable |
2,543,003.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
203,482.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,037.12 |
| Other Current Liabilities |
1,239,479.15 |
| Sub-Total of Current Liabilities |
276,966,490.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,027,211.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,999,936.37 |
| Total Liabilities |
281,966,427.10 |
| Paid-In Capital(Or Share Stock) |
100,000,000.00 |
| Capital Surplus |
222,342,803.61 |
| Surplus Reserve |
26,825,474.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
202,477,702.88 |
| Minority Stockholder's Interest |
13,356,604.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
551,637,138.00 |
| Owner's Equity（Stockholder's Equity） |
564,993,742.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
846,960,170.02 |
